COVID-19 cases, hospitalizations and deaths after vaccination: a cohort event monitoring study, Islamic Republic of Iran/[phrase omitted]/[phrase omitted]/Cas, hospitalisations et deces lies a la COVID-19 apres la vaccination: etude de cohorte portant sur la surveillance des evenements en Republique islamique d'Iran/[phrase omitted]/Casos, hospitalizaciones y muertes por la COVID-19 tras la vacunacion: un estudio de cohortes sobre el seguimiento de eventos en la Republica Islamica de Iran

• Published in: Bulletin of the World Health Organization Vol. 100; no. 8; pp. 474 - 483
• Main Authors: Hosseinzadeh, Ali, Sahab-Negah, Sajad, Nili, Sairan, Aliyari, Roqayeh, Goli, Shahrbanoo, Fereidouni, Mohammad, Alami, Ali, Shati, Mohsen, Ahmadnezhad, Elham, Mehravaran, Shiva, Fateh, Mansooreh, Khajeha, Hamidreza, Emamian, Zahra, Behmanesh, Elahe, Mahdavi, Sepideh, Enayatrad, Mostafa, shahrbabaki, Parvin Mangolian, Ansari-Moghaddam, Alireza, Heidarzadeh, Abtin, Shahraki-Sanavi, Fariba, Shahri, Seyed Mohammad Hashemi, Dehghan, Mahlagha, Moridani, Mohammadreza Amini, Sheibani, Hossein, Abbaszadeh, Maryam, Jafari, Reza, Valikhani, Maryam, Binesh, Ehsan, Vahedi, Hamid, Chaman, Reza, Khodashahi, Rozita, Amini, Mahnaz, Azad, Farahzad Jabbari, Rezaeitalab, Fariborz, Jamehdar, Saeid Amel, Eshraghi, Ali, Sharifi, Hamid, Bajgani, Seyed Mehdi Hashemi, Mahdavi, Amin, Jafarzadeh, Abdollah, Farokhnia, Mehrdad, Ebrahimi, Saeedeh, Pardakhti, Abbas, Ghaderi, Ebrahim, Soltani, Hasan, Jadidoleslami, Sedigh, Arianejad, Anoush, Gavili, Hamed, Moradveisi, Borhan, Motamedi, Dina, Zare, Hamed, Kazemi, Toba, Emamian, Mohammad Hassan
• Format: Journal Article
• Language: English
• Published: World Health Organization 01.08.2022
• Subjects: Analysis; Comorbidity; Complications and side effects; Coronaviruses; Kidney diseases; Medical research; Medicine, Experimental; Risk factors; Surveys; Vaccination; Iran
• ISSN: 0042-9686; 1564-0604
• DOI: 10.2471/BLT.22.288073

[phrase omitted] [phrase omitted] Metodos Se inscribieron personas de 18 anos o mas que recibieron su primera dosis de la vacuna contra la COVID-19 entre abril de 2021 y enero de 2022 en siete ciudades iranies. Los participantes completaron encuestas de seguimiento semanales durante 17 semanas (25 semanas para AZD1222) para informar sobre su estado de la COVID-19 y la hospitalizacion. Se utilizaron modelos de regresion de Cox para valorar los factores de riesgo de contraer la COVID-19, de ser hospitalizado y de morir.